» Articles » PMID: 19015243

CUX1 and E2F1 Regulate Coordinated Expression of the Mitotic Complex Genes Ect2, MgcRacGAP, and MKLP1 in S Phase

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2008 Nov 19
PMID 19015243
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Rho GTPases are critical for mitosis progression and completion of cytokinesis. During mitosis, the GDP/GTP cycle of Rho GTPases is regulated by the exchange factor Ect2 and the GTPase activating protein MgcRacGAP which associates with the kinesin MKLP1 in the centralspindlin complex. We report here that expression of Ect2, MgcRacGAP, and MKLP1 is tightly regulated during cell cycle progression. These three genes share similar cell cycle-related signatures within their promoter regions: (i) cell cycle gene homology region (CHR) sites located at -20 to +40 nucleotides of their transcription start sites that are required for repression in G(1), (ii) E2F binding elements, and (iii) tandem repeats of target sequences for the CUX1 transcription factor. CUX1 and E2F1 bind these three promoters upon S-phase entry, as demonstrated by chromatin immunoprecipitation, and regulate transcription of these genes, as established using promoter-luciferase reporter constructs and expression of activated or dominant negative transcription factors. Overexpression of either E2F1 or CUX1 increased the levels of the endogenous proteins whereas small interfering RNA knockdown of E2F1 or use of a dominant negative E2F1 reduced their expression levels. Thus, CUX1, E2F, and CHR elements provide the transcriptional controls that coordinate induction of Ect2, MgcRacGAP, and MKLP1 in S phase, leading to peak expression of these interacting proteins in G(2)/M, at the time they are required to regulate cytokinesis.

Citing Articles

Contribution of ECT2 to Tubulointerstitial Fibrosis in the Progression of Chronic Kidney Disease.

Song K, Su H Curr Med Sci. 2024; 44(6):1249-1258.

PMID: 39460889 DOI: 10.1007/s11596-024-2948-1.


Identification and characterization of the mediator kinase-dependent myometrial stem cell phosphoproteome.

Barron L, Khadka S, Schenken R, He L, Blenis J, Blagg J F S Sci. 2022; 2(4):383-395.

PMID: 35559861 PMC: 10906282. DOI: 10.1016/j.xfss.2021.09.003.


Loss of a 7q gene, CUX1, disrupts epigenetically driven DNA repair and drives therapy-related myeloid neoplasms.

Imgruet M, Lutze J, An N, Hu B, Khan S, Kurkewich J Blood. 2021; 138(9):790-805.

PMID: 34473231 PMC: 8414261. DOI: 10.1182/blood.2020009195.


Epithelial cell transforming 2 is regulated by Yes-associated protein 1 and mediates pancreatic cancer progression and metastasis.

Li C, Peng Z, Wang Y, Lam G, Nissen N, Tang J Am J Physiol Gastrointest Liver Physiol. 2021; 320(3):G380-G395.

PMID: 33501895 PMC: 8202240. DOI: 10.1152/ajpgi.00185.2020.


KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target.

Gao C, Ren J, Yu J, Li S, Guo X, Zhou Y Ann Transl Med. 2020; 8(21):1394.

PMID: 33313139 PMC: 7723550. DOI: 10.21037/atm-20-1970.


References
1.
Eguchi T, Takaki T, Itadani H, Kotani H . RB silencing compromises the DNA damage-induced G2/M checkpoint and causes deregulated expression of the ECT2 oncogene. Oncogene. 2006; 26(4):509-20. DOI: 10.1038/sj.onc.1209810. View

2.
Henglein B, Chenivesse X, Wang J, Eick D, Brechot C . Structure and cell cycle-regulated transcription of the human cyclin A gene. Proc Natl Acad Sci U S A. 1994; 91(12):5490-4. PMC: 44021. DOI: 10.1073/pnas.91.12.5490. View

3.
Sansregret L, Goulet B, Harada R, Wilson B, Leduy L, Bertoglio J . The p110 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell Biol. 2006; 26(6):2441-55. PMC: 1430290. DOI: 10.1128/MCB.26.6.2441-2455.2006. View

4.
Bustelo X, Sauzeau V, Berenjeno I . GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 2007; 29(4):356-70. PMC: 1971132. DOI: 10.1002/bies.20558. View

5.
Zhu W, Giangrande P, Nevins J . E2Fs link the control of G1/S and G2/M transcription. EMBO J. 2004; 23(23):4615-26. PMC: 533046. DOI: 10.1038/sj.emboj.7600459. View